Cargando…

A CREB1-miR-181a-5p loop regulates the pathophysiologic features of bone marrow stromal cells in fibrous dysplasia of bone

BACKGROUND: Fibrous dysplasia (FD) is a bone marrow stromal cell (BMSC) disease caused by activating mutations of guanine nucleotide-binding protein alpha-stimulating activity polypeptide (GNAS) and is characterized by increased proliferative activity and disrupted osteogenesis of BMSCs. However, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yu, Xin, Zhili, Ling, Ziji, Xie, Hanyu, Xiao, Tao, Shen, Xin, Lin, Jialin, Xu, Ling, Jiang, Hongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296714/
https://www.ncbi.nlm.nih.gov/pubmed/34294046
http://dx.doi.org/10.1186/s10020-021-00341-z
_version_ 1783725701843648512
author Fu, Yu
Xin, Zhili
Ling, Ziji
Xie, Hanyu
Xiao, Tao
Shen, Xin
Lin, Jialin
Xu, Ling
Jiang, Hongbing
author_facet Fu, Yu
Xin, Zhili
Ling, Ziji
Xie, Hanyu
Xiao, Tao
Shen, Xin
Lin, Jialin
Xu, Ling
Jiang, Hongbing
author_sort Fu, Yu
collection PubMed
description BACKGROUND: Fibrous dysplasia (FD) is a bone marrow stromal cell (BMSC) disease caused by activating mutations of guanine nucleotide-binding protein alpha-stimulating activity polypeptide (GNAS) and is characterized by increased proliferative activity and disrupted osteogenesis of BMSCs. However, the molecular mechanisms regulating the pathophysiologic features of BMSCs in FD remain unknown. This study aimed to identify and verify the roles of the CREB1-miR-181a-5p regulatory loop in FD pathophysiology. METHODS: MicroRNA (miRNA) sequencing analysis was used to identify the possible miRNAs implicated in FD. The proliferation, apoptosis, and osteogenic differentiation of BMSCs, as well as the osteoclast-induced phenotype, were measured and compared after exogenous miR-181a-5p transfection into FD BMSCs or miR-181a-5p inhibitor transfection into normal BMSCs. Chromatin immunoprecipitation and luciferase reporter assays were performed to verify the interactions between CREB1 and miR-181a-5p and their effects on the FD pathological phenotype. RESULTS: Compared to normal BMSCs, FD BMSCs showed decreased miR-181a-5p levels and exhibited increased proliferative activity, decreased apoptotic capacity, and impaired osteogenesis. FD BMSCs also showed a stronger osteoclast activation effect. miR-181a-5p overexpression reversed the pathophysiologic features of FD BMSCs, whereas miR-181a-5p suppression induced an FD-like phenotype in normal BMSCs. Mechanistically, miR-181a-5p was the downstream target of CREB1, and CREB1 was posttranscriptionally regulated by miR-181a-5p. CONCLUSIONS: Our study identifies that the interaction loop between CREB1 and miR-181a-5p plays a crucial role in regulating the pathophysiologic features of FD BMSCs. MiR-181a-5p may be a potential therapeutic target for the treatment of FD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-021-00341-z.
format Online
Article
Text
id pubmed-8296714
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82967142021-07-22 A CREB1-miR-181a-5p loop regulates the pathophysiologic features of bone marrow stromal cells in fibrous dysplasia of bone Fu, Yu Xin, Zhili Ling, Ziji Xie, Hanyu Xiao, Tao Shen, Xin Lin, Jialin Xu, Ling Jiang, Hongbing Mol Med Research Article BACKGROUND: Fibrous dysplasia (FD) is a bone marrow stromal cell (BMSC) disease caused by activating mutations of guanine nucleotide-binding protein alpha-stimulating activity polypeptide (GNAS) and is characterized by increased proliferative activity and disrupted osteogenesis of BMSCs. However, the molecular mechanisms regulating the pathophysiologic features of BMSCs in FD remain unknown. This study aimed to identify and verify the roles of the CREB1-miR-181a-5p regulatory loop in FD pathophysiology. METHODS: MicroRNA (miRNA) sequencing analysis was used to identify the possible miRNAs implicated in FD. The proliferation, apoptosis, and osteogenic differentiation of BMSCs, as well as the osteoclast-induced phenotype, were measured and compared after exogenous miR-181a-5p transfection into FD BMSCs or miR-181a-5p inhibitor transfection into normal BMSCs. Chromatin immunoprecipitation and luciferase reporter assays were performed to verify the interactions between CREB1 and miR-181a-5p and their effects on the FD pathological phenotype. RESULTS: Compared to normal BMSCs, FD BMSCs showed decreased miR-181a-5p levels and exhibited increased proliferative activity, decreased apoptotic capacity, and impaired osteogenesis. FD BMSCs also showed a stronger osteoclast activation effect. miR-181a-5p overexpression reversed the pathophysiologic features of FD BMSCs, whereas miR-181a-5p suppression induced an FD-like phenotype in normal BMSCs. Mechanistically, miR-181a-5p was the downstream target of CREB1, and CREB1 was posttranscriptionally regulated by miR-181a-5p. CONCLUSIONS: Our study identifies that the interaction loop between CREB1 and miR-181a-5p plays a crucial role in regulating the pathophysiologic features of FD BMSCs. MiR-181a-5p may be a potential therapeutic target for the treatment of FD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-021-00341-z. BioMed Central 2021-07-22 /pmc/articles/PMC8296714/ /pubmed/34294046 http://dx.doi.org/10.1186/s10020-021-00341-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Fu, Yu
Xin, Zhili
Ling, Ziji
Xie, Hanyu
Xiao, Tao
Shen, Xin
Lin, Jialin
Xu, Ling
Jiang, Hongbing
A CREB1-miR-181a-5p loop regulates the pathophysiologic features of bone marrow stromal cells in fibrous dysplasia of bone
title A CREB1-miR-181a-5p loop regulates the pathophysiologic features of bone marrow stromal cells in fibrous dysplasia of bone
title_full A CREB1-miR-181a-5p loop regulates the pathophysiologic features of bone marrow stromal cells in fibrous dysplasia of bone
title_fullStr A CREB1-miR-181a-5p loop regulates the pathophysiologic features of bone marrow stromal cells in fibrous dysplasia of bone
title_full_unstemmed A CREB1-miR-181a-5p loop regulates the pathophysiologic features of bone marrow stromal cells in fibrous dysplasia of bone
title_short A CREB1-miR-181a-5p loop regulates the pathophysiologic features of bone marrow stromal cells in fibrous dysplasia of bone
title_sort creb1-mir-181a-5p loop regulates the pathophysiologic features of bone marrow stromal cells in fibrous dysplasia of bone
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296714/
https://www.ncbi.nlm.nih.gov/pubmed/34294046
http://dx.doi.org/10.1186/s10020-021-00341-z
work_keys_str_mv AT fuyu acreb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT xinzhili acreb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT lingziji acreb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT xiehanyu acreb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT xiaotao acreb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT shenxin acreb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT linjialin acreb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT xuling acreb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT jianghongbing acreb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT fuyu creb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT xinzhili creb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT lingziji creb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT xiehanyu creb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT xiaotao creb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT shenxin creb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT linjialin creb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT xuling creb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone
AT jianghongbing creb1mir181a5ploopregulatesthepathophysiologicfeaturesofbonemarrowstromalcellsinfibrousdysplasiaofbone